On an adjusted basis, the 2019 fiscal third-quarter loss totaled $6.1 million, or 13 cents per share. The life sciences and biotechnology company posted ...
News
- Enzo Biochem: Fiscal 3Q Earnings Snapshot
- US Presidential Scholar Award recognizes local student
“I'm going to Duke University next year to the School of Engineering for biomedical engineering,” Lloyd said. Just a few weeks ago, results were ...
- National coronavirus updates: Confirmed coronavirus cases worldwide rising faster than ever
The U.S. Biomedical Advanced Research and Development Authority, a part of the Department of Health and Human Services, is funding research on ...
- Initial public offerings scheduled to debut next week
Business: Biotech redeveloping abandoned drugs for non-small cell lung cancer. uCloudlink - Hong Kong, 2.6 million shares, priced $18-$20.50, ...
- Medical research, clinical trials for most diseases take a hit amid pandemic panic
Based on Gentry's work, a small biotech company, Valerion Therapeutics, has recently begun drug-safety studies in macaques. But that work can't be ...